Artwork for podcast The Menopause and Cancer Podcast
Ep 06: HRT after Breast Cancer? Why Opinions Divide with Mr Vikram Talaulikar
Episode 626th July 2022 • The Menopause and Cancer Podcast • Dani Binnington
00:00:00 00:33:08

Share Episode

Shownotes

Today’s episode is sponsored by BySarahLondon, award-winning natural skincare brand by founders and sisters Sarah and Lauren.

Enjoy an exclusive 20% off at bysarahlondon.com. Type in code DANI20 (excludes bundles, one use per person)


 


Is it possible to take HRT after hormone-sensitive cancer?


This is one of the questions where experts’ opinions divide, leaving patients confused. Once you’re given a ‘no to HRT’ it can make us feel as if we have no options.


I will speak about HRT after cancer more in future episodes on the podcast because I know so many of us are in a muddle about this. And I will try to learn from experts and patients what their individual thought processes are.


But for today, I am trying to understand from our guest expert what we know from all the studies that have been done. Even if your cancer was not hormone-driven this episode is a must-listen-to - it will give a greater understanding of where we are at.


Our guest today is the incredibly knowledgable Mr. Vikram Talaulikar, associate specialist at the reproductive medicine unit and associate Professor in Women's Health at University College London Hospitals NHS Foundation Trust.


He has published widely in the area of reproductive medicine and explains to us what we know and what we don’t know and how he handles this in his day-to-day practice.


 


Mr. Talaulikar: https://www.menopausecliniclondon.co.uk/about-us


Or Instagram: @menopausecliniclondon


 


Here are the highlights:


(04:55) Why do we have such opposing opinions?


(06:20) How does Tamoxifen or AI’s work on the body?


(09:59) How the breast cancer treatment works and its possible side-effects


(15:15) The randomised trials in the area of HRT after breast cancer


(21:44) It has to be a woman’s choice


(26:11) Do we include our medical team in our conversation about HRT?


 




 

Follow

Links